SODIUM METHYL N-(13-CIS-RETINOYL)-L-CYSTEOATE
UNII W2D49SIY40

Substance Identification & Data

This profile provides standardized clinical and technical data for Sodium Methyl N-(13-cis-retinoyl)-l-cysteoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W2D49SIY40.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1161832-05-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

W2D49SIY40

CAS Registry Number

1161832-05-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SODIUM METHYL N-(13-CIS-RETINOYL)-L-CYSTEOATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H34NO6S.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UDNDGNMOQGQRJT-GPVFVYNBSA-M

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

154824285

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[Na+].C(\C1=C(C)CCCC1(C)C)=C/C(/C)=C/C=C/C(/C)=C\C(=O)N[C@H](C(=O)OC)CS([O-])(=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sodium Methyl N-(13-cis-retinoyl)-l-cysteoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.